增生型糖尿病视网膜病变黄斑裂孔的手术治疗

Vitrectomy for proliferative diabetic retinopathy with macular hole

目的 评价玻璃体切割术治疗增生型糖尿病视网膜病变黄斑裂孔疗效 ,并分析有关因素。方法 12例增生型糖尿病视网膜病变黄斑裂孔患者接受玻璃体切割术治疗。硅油填充 3眼 ,18%C3 F8填充 9眼。平均随访 6个月 ( 3～ 2 4个月 )。结果 黄斑裂孔闭合率 83%( 10 / 12 ) ,视网膜复位率 83%( 10 / 12 )。术后视力提高 10眼 ( 83%,10 / 12 ) ,不变 2眼( 17%,2 / 12 )。并发症主要包括术后短暂高眼压 2眼 ,晶状体核硬化 3眼 ,视网膜脱离复发 2眼。结论 玻璃体切割术是治疗增生型糖尿病视网膜病变黄斑裂孔安全有效的方法。

ObjectiveTo evaluate the efficacy of vitrectomy for proliferative diabetic retinopathy with macular hole and to analyze the relavent factors.MethodsTwelve proliferative diabetic retinopathy patients with macular hole underwent vitrectomy surgeries.Silicone oil was injected in 3 eyes,and 18% C 3F 8 in 9 eyes.The mean follow-up period was 6 months (3～24 months).ResultsMacular hole closure rate was 83%(10/12),and the retina attachment rate was 83%(10/12).The visual acuity increased in 10 eyes (83%,10/12),and no changed in 2 eyes (17%,2/12).Postoperative complications mainly included temporary intraocular pressure elevation(2 eyes),lense nucleus sclerosis (3 eyes)and retinal redetachment (2 eyes).ConclusionVitrectomy is an effective method in treating proliferative diabetic retinopathy with macular hole.